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Background
Immunogen development for HIV-1 vaccines can be
based on epitope identification of naturally occurring
neutralizing antibodies in HIV-1 infected patients. A
neutralizing monoclonal antibody, HJ16, was obtained at
IRB from a patient recruited at ITM which recognized a
new epitope in the CD4bs and neutralized mostly tier 2
s t r a i n st h a tw e r en o tn e u t r a l i z e db yb 1 2 [ 1 ] .T h i sn e w
CD4bs epitope is not fully characterized yet but could
be important for immunogen design. We therefore used
a neutralization sensitive virus and after resistance
induction compared the resistant and sensitive strains to
map important regions for the HJ16 neutralizing
activity.
Materials and methods
HJ16 resistance was induced by culturing the sensitive
replication competent VI1090 (CRFO2_AG) strain (IC50
0.10 µg/ ml) in increasing amounts of HJ16 on freshly
isolated PBMC until a resistant strain was obtained that
was able to replicate in almost 200 µg/ml HJ16. Neutra-
lizing activity was measured using TZMbl and PBMC
neutralization assays. Site-directed mutagenesis was car-
ried out to induce the observed mutations into the
VI1090 expressing vector.
Results
Sequencing of the HJ16 sensitive versus the resistant
strain revealed a distinct point mutation where the neu-
tral asparagine was replaced by the negative charged
aspartic acid. This N276D point mutation is only seen
in 0.69% of the group M strains described in the Los
Alamos database (total of 1885 viruses, 6 cases with
N276D and 7 cases with a polar N276S mutation).
Introduction of this mutation into the HJ16 neutraliza-
tion sensitive construct rendered the mutated strain
resistant to neutralization by at least 100 fold higher
HJ16 concentration.
Conclusions
Results show that the mutation in the N-linked glycosy-
lation site at N276 has a distinct influence on sensitivity
to the HJ16 CD4bs antibody. Although it is disappoint-
ing that a single mutation seems to induce resistance it
is obvious that this mutation is quite unique and occurs
rarely in natural infection rendering this epitope very
suitable for further vaccine development.
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